Name
Abstract | ||
|---|---|---|
The aim of the overview is to give a perspective of global biobank development is given in a view of positioning biobanking as a key resource for healthcare to identify new potential markers that can be used in patient diagnosis and complement the targeted personalized drug treatment. The fast progression of biobanks around the world is becoming an important resource for society where the patient benefit is in the focus, with a high degree of personal integrity and ethical standard. Biobanks are providing patient benefits by large scale screening studies, generating large database repositories. It is envisioned by all participating stakeholders that the biobank initiatives will become the future gateway to discover new frontiers within life science and patient care. There is a great importance of biobank establishment globally, as biobanks has been identified as a key area for development in order to speed up the discovery and development of new drugs and protein biomarker diagnostics. One of the major objectives in Europe is to establish concerted actions, where biobank networks are being developed in order to combine and have the opportunity to share and build new science and understanding from complex disease biology. These networks are currently building bridges to facilitate the establishments of best practice and standardizations. |
Year | DOI | Venue |
|---|---|---|
2011 | 10.1186/2043-9113-1-24 | J. Clinical Bioinformatics |
Keywords | DocType | Volume |
health informatics,bioinformatics,human proteome project,health care,biobank,biomarkers,biomedical research | Journal | 1 |
Issue | ISSN | Citations |
1 | 2043-9113 | 3 |
PageRank | References | Authors |
0.48 | 0 | 5 |
Name | Order | Citations | PageRank |
|---|---|---|---|
| Ákos Végvári | 1 | 3 | 0.81 |
| Charlotte Welinder | 2 | 3 | 0.48 |
| Henrik Lindberg | 3 | 3 | 0.48 |
| Thomas E. Fehniger | 4 | 3 | 0.81 |
| György Marko-Varga | 5 | 30 | 2.39 |